Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal Cord Neoplasms”

268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 268 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002034
What this trial is testing

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

Who this might be right for
Adjustment Disorder
Reunion Neuroscience Inc 100
Large-scale testing (Phase 3)Ended earlyNCT05328908
What this trial is testing

Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Bristol-Myers Squibb 770
Not applicableNo Longer AvailableNCT03874455
What this trial is testing

Tazemetostat Expanded Access Program for Adults With Solid Tumors

Who this might be right for
Epithelioid Sarcoma (Ex-US Only)Spindle Cell SarcomaSinonasal Carcinoma+17 more
Epizyme, Inc.
Not applicableStudy completedNCT03942952
What this trial is testing

PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingNeuromyelitis OpticaAcute Disseminated Encephalomyelitis+1 more
University of Texas Southwestern Medical Center 49
Not applicableUnknownNCT00154960
What this trial is testing

Establishing Novel Detection Techniques for Various Genetic-Related Diseases by Applying DHPLC Platform.

Who this might be right for
Spinal Muscular AtrophyNeonatal HyperbilirubinemiaColon Cancer
National Taiwan University Hospital 1,000
Not applicableEnded earlyNCT02225223
What this trial is testing

Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s)

Who this might be right for
Metastatic Lesions in Vertebral Bodies
Merit Medical Systems, Inc. 35
Post-approval studies (Phase 4)Study completedNCT02052024
What this trial is testing

Myobloc Atrophy Study

Who this might be right for
Spasticity Secondary to Either a Disorder or TraumaSpinal Cord Injury (SCI)Brain Injury+2 more
Georgetown University 10
Early research (Phase 1)Temporarily pausedNCT01337518
What this trial is testing

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Enzon Pharmaceuticals, Inc. 150
Not applicableStudy completedNCT03516994
What this trial is testing

Reducing Disparities in the Quality of Advance Care Planning for Older Adults

Who this might be right for
Metastatic CancerCongestive Heart FailureChronic Obstructive Pulmonary Disease+6 more
Duke University 790
Not applicableUnknownNCT03632005
What this trial is testing

Negative Pressure Wound Therapy vs. Sterile Dressing for Patients Undergoing Thoracolumbar Spine Surgery

Who this might be right for
Metastatic DiseaseSpinal Cord InjurySpinal Degeneration+1 more
John Street 550
Testing effectiveness (Phase 2)Study completedNCT03437941
What this trial is testing

Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics 39
Testing effectiveness (Phase 2)Ended earlyNCT04926181
What this trial is testing

Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer

Who this might be right for
Small Cell Neuroendocrine CarcinomaProstate CancerSmall Cell Carcinoma
Rahul Aggarwal 2
Testing effectiveness (Phase 2)Study completedNCT02591901
What this trial is testing

Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

Who this might be right for
UTINeurogenic BladderAntibiotic Resistance
Buckinghamshire Healthcare NHS Trust 48
Not applicableLooking for participantsNCT04863612
What this trial is testing

SBRT in the Management of Solid Spinal Metastases

Who this might be right for
Extradural TumorSpinal Metastases
Universitaire Ziekenhuizen KU Leuven 100
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Early research (Phase 1)Active Not RecruitingNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Not applicableActive Not RecruitingNCT00445367
What this trial is testing

Biobank For MS And Other Demyelinating Diseases

Who this might be right for
Multiple SclerosisTransverse MyelitisNeuromyelitis Optica+2 more
Accelerated Cure Project for Multiple Sclerosis 3,226
Not applicableEnded earlyNCT03843073
What this trial is testing

Connected Catheter- Safety and Effectiveness Study

Who this might be right for
Urinary RetentionNeurogenic BladderUrologic Diseases
Spinal Singularity 9
Testing effectiveness (Phase 2)Study completedNCT03642067
What this trial is testing

Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer

Who this might be right for
Microsatellite Stable (MSS) Colorectal AdenocarcinomasColorectal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 59
Load More Results